Search
Triamcinolone Nasal (Nasocort)
FDA approves OTC Nasocort 2013.
Indications:
- treatment of hayfever & allergic rhinitis
Dosage:
- start 2 sprays (110 ug) QD, max 4 sprays/day
Adverse effects:
1) irritation of nasal mucosa
2) rarely nasal ulceration
Mechanism of action:
1) does NOT inhibit IgE synthesis or mast cell degranulation
2) inhibits cytokine production, arachidonate metabolism, inflammation & mast cell proliferation
Interactions
drug adverse effects of glucocorticoids
monitor with drug (more general terms)
General
triamcinolone (TAC, Arsitospan, Kenalog, Trivaris)
nasal agent
References
- FDA News. October 11, 2013
FDA approves over-the-counter Nasacort Allergy 24HR to treat
hay fever and nasal allergies.
http://www.fda.gov/Drugs/NewsEvents/ucm370973.htm